Ginkgo Bioworks Holdings, Inc. (DNA)
8.50
-1.11
(-11.55%)
USD |
NYSE |
Nov 16, 16:00
8.56
+0.06
(+0.71%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Profit Margin (Quarterly) : -147.9% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -147.9% |
| June 30, 2026 | -284.4% |
| March 31, 2026 | -390.6% |
| December 31, 2025 | -241.8% |
| September 30, 2025 | -249.7% |
| June 30, 2025 | -135.9% |
| March 31, 2025 | -217.9% |
| December 31, 2024 | -245.2% |
| September 30, 2024 | -63.34% |
| June 30, 2024 | -386.4% |
| March 31, 2024 | -437.3% |
| December 31, 2023 | -609.1% |
| September 30, 2023 | -546.4% |
| Date | Value |
|---|---|
| June 30, 2023 | -215.1% |
| March 31, 2023 | -254.0% |
| December 31, 2022 | -177.2% |
| September 30, 2022 | -1.01K% |
| June 30, 2022 | -463.7% |
| March 31, 2022 | -351.9% |
| December 31, 2021 | -1.08K% |
| September 30, 2021 | -131.9% |
| June 30, 2021 | -124.8% |
| March 31, 2021 | -169.6% |
| December 31, 2020 | -144.7% |
| September 30, 2020 | -196.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sotera Health Co. | 17.97% |
| CareDx, Inc. | 13.84% |
| Exagen, Inc. | -34.40% |
| Quest Diagnostics, Inc. | 10.46% |
| Labcorp Holdings, Inc. | 6.91% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.88% |
| Return on Assets | -24.17% |
| Return on Invested Capital | -29.00% |
| Gross Profit Margin (Quarterly) | 50.04% |
| Operating Margin (Quarterly) | -157.6% |
| Return on Net Operating Assets | -43.48% |